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Background/Aims: Gastric dysplasia is generally accepted 
to be the precursor lesion of gastric carcinoma. Approxi-
mately 25% to 35% of histological diagnoses based on endo-
scopic forcep biopsies for gastric dysplastic lesions change 
following endoscopic resection (ER). The aim of this study 
was to determine the predictive endoscopic features of high-
grade gastric dysplasia (HGD) or early gastric cancer (EGC) 
following ER for lesions initially diagnosed as low-grade dys-
plasia (LGD) by a forceps biopsy. Methods: To determine pre-
dictive variables for upgraded histology (LGD to HGD or EGC). 
The lesion size, gross endoscopic appearance, location, and 
surface nodularity or redness as well as the presence of a 
depressed portion, Helicobacter pylori infection, and intes-
tinal metaplasia were retrospectively investigated. Results: 
Among 251 LGDs diagnosed by an initial forceps biopsy, the 
diagnoses of 100 lesions (39.8%) changed following the 
ER; 56 of 251 LGDs (22.3%) were diagnosed as HGD, 39 
(15.5%) as adenocarcinoma, and 5 (2.0%) as chronic gas-
tritis. In a univariate analysis, large lesions (>15 mm), those 
with a depressed portion, and those with surface nodularity 
were signiﬁ  cantly correlated with a upgraded histology clas-
siﬁ  cation following ER. In a multivariate analysis, a large size 
(>15 mm; odds ratio [OR], 2.8; 95% conﬁ  dence interval [CI], 
1.46 to 5.43) and a depressed portion in the lesion (OR, 2.7; 
95% CI, 1.44 to 5.03) were predictive factors for upgraded 
histology following ER. Conclusions: Our study shows that 
a substantial proportion of diagnoses of low-grade gastric 
dysplasias based on forceps biopsies were not representa-
tive of the entire lesion. We recommend ER for lesions with 
a depressed portion and for those larger than 15 mm. (Gut 
Liver 2011;5:187-193)
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INTRODUCTION
Dysplasia refers to an unequivocal neoplastic transformation 
in the epithelium without penetration into the lamina propria 
(intramucosal carcinoma).
1,2 Gastric dysplasia is generally ac-
cepted to be a precursor lesion for gastric carcinoma.
3 The 
chance of carcinoma developing from gastric dysplasia may 
depend on the histological type and grade, size, and surface 
appearance of the gastric dysplasia.
4,5 Therefore, a lesion diag-
nosed as high-grade dysplasia (HGD; category 4 in the Vienna 
classification) based on pathological examination of endoscopic 
forceps biopsy specimens should be considered for endoscopic 
resection (ER).
6,7 
In contrast to HGD, however, there is controversy as to what 
the best treatment option is for low-grade dysplasia (LGD). 
Some authors have asserted that endoscopic surveillance with 
re-biopsy should be scheduled periodically because of the low 
risk of malignant transformation,
8,9 whereas others have sug-
gested that the guiding principle for the management of LGD 
should be ER of the lesion.
5,10 If the endoscopic forceps biopsy is 
representative of the entire lesion, endoscopic follow-up should 
be sufficient to manage LGD. However, a finding of low-grade 
dysplasia (category 3 in the Vienna classification) based on 
forceps biopsy material does not completely exclude the pres-
ence of HGD or carcinoma in other parts of the lesion.
4,11,12 In 
particular, even though accurate diagnostic information can be 
obtained via endoscopic forceps biopsy, the histological discrep-
ancy between endoscopic forceps biopsy specimens and ER has 
been reported to range from 25% to 40%.
13-16 In this study, we 
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investigated the predictive endoscopic features of HGD or early 
gastric cancer (EGC) of lesions originally diagnosed as LGD based 
on a forceps biopsy. 
MATERIALS AND METHODS
1. Study population
From July 2005 to May 2009, 241 patients diagnosed with 
LGD lesions by initial endoscopic forceps biopsy were retrospec-
tively enrolled and underwent ER at Yonsei University Wonju 
Christian Hospital, Korea. This study was approved by the local 
Institutional Review Board, Yonsei University Wonju College 
of Medicine, Wonju, Korea and all patients were provided writ-
ten informed consent to participate in the study. After ER, all 
lesions were assigned to one of two groups based on the final 
histological findings: an up-graded histology group (UH; LGD 
to HGD or EGC) or a concordant histology group (CDH; LGD to 
gastritis or LGD).
2. Methods
ER was performed by endoscopic mucosal resection (EMR) or 
endoscopic submucosal dissection (ESD). Gastric lesions were 
first identified and demarcated using white-light endoscopy and 
chromoendoscopy with an indigo-carmine solution (GIF-Q 240, 
260; Olympus Optical Co., Ltd., Tokyo, Japan). Marking around 
the lesions was achieved with spotty cautery using argon plasma 
coagulation. Isotonic saline mixed with epinephrine (1:10,000) 
was injected into the submucosal layer to produce a mucosal 
bleb. A circumferential mucosal incision was made around the 
lesion and then resection with a snare (EMR or polypectomy) 
or a hook knife and/or insulated tipped knife (Olympus Optical 
Co., Ltd.) ESD was performed. All patients were sedated by in-
travenous injection of 3 to 4 mg of midazolam and/or 20 mg of 
propofol. Ten to 20 mg of propofol was additionally given for 
conscious sedation as needed throughout the procedure.
To determine predictive variables for UH, the size, number 
of forceps biopsy specimens, location of the dysplastic lesion, 
surface nodularity or redness, presence of a depressed portion, 
Helicobacter pylori infection, and intestinal metaplasia were 
retrospectively investigated as potential factors. The location of 
the dysplastic lesion, surface nodularity and redness, and the 
presence of a depressed portion were investigated by white-light 
endoscopy and chromoendoscopy using indigo-carmine. A mu-
cosal depressed portion was defined as any lesions with muco-
sal defect, erosion, or scar. Surface nodularity of the membrane 
to have the curvature of 2 mm or more was defined as positive. 
The size of the dysplastic lesion, presence of H. pylori infection, 
and coexistence of intestinal metaplasia were extracted from the 
pathology report of the resected specimen.
One expert gastrointestinal pathologist reviewed the histopath-
ological findings of both endoscopic forceps biopsy materials and 
the endoscopically resected specimen. Biopsy specimens from the 
gastric lesion were fixed in formalin and bisected for hematoxy-
lin-eosin (H&E) staining. The resected specimens were also fixed 
on a flat board and observed macroscopically; they were then 
fixed in formalin and examined in step sections. The resected 
specimens were sectioned perpendicularly at 2 mm intervals. All 
of the lesions were classified according to the standardized Vi-
enna classification guidelines for gastrointestinal neoplasia.
12
3. Statistical analysis
All statistical tests performed were two-sided tests and a p 
value of less than 0.05 was considered statistically significant. 
Statistical analyses were performed using the SPSS PC software 
program (SPSS Inc., Chicago, IL, USA). Associations between 
the categorical parameters and sub-groups of UH and CDH were 
assessed by the chi-square test. Multiple logistic regression anal-
yses to determine predictive factors for an upgraded histology 
after ER were performed to examine the effects of independent 
variables, and adjustments were made for the effects of each of 
the variables on the other variables. Medical statistician sup-
ported the study design and analysis of data.
RESULTS
1. Clinicopathological characteristics of the patients and 
their gastric lesions
A total of 241 patients (mean age, 62.6±10 years; M:F=175:66) 
were enrolled in this study, for a total of 251 lesions. Among 
241 cases, 23 (9.5%) have multiple lesions; 21 cases had double 
lesions and the rest 2 had triple lesions. All of multiple lesions, 
the initial biopsies were performed in 10 cases. The mean size 
of the lesions was 12.8±7.9 mm and the number of forceps 
biopsies performed per lesion was 2.5±1.3. When we divided 
the gastric area into three sections (fundus, angle, and antrum), 
160 cases were located on the antrum. The frequencies of a de-
Table 1. Histological Comparison of Forceps Biopsy Specimens and 
Resected Specimens
Variable




Gastritis*   5 (2.0)
151 (60.2)
  56 (22.3)









    CIS
    WD
    MD
Total 251
LGD, low-grade dysplasia; HGD, high-grade dysplasia; CIS, carci-
noma in situ; WD, well differentiated; MD, moderately differentiated.
*Concordant or down-graded histology (CDH) group; 
̈Up-graded 
histology (UH) group.Won CS, et al: Endoscopic Features of Upgraded Histology of Gastric Dysplasia  189
pressed portion, surface nodularity, and redness were 46%, 55%, 
and 39%, respectively. The frequencies of H. pylori infection 
and intestinal metaplasia were 48% and 85%, respectively.
2. Histological comparison between forcep biopsy speci-
mens and resected specimens
Among 241 patients diagnosed with LGD on forceps biopsy, 
151 cases (60%) showed a concordant histology after ER where-
as 100 cases (40%) had a different histology: 39 cases of adeno-
carcinoma, 56 cases of HGD, and 5 cases of chronic gastritis. 
Among 39 cases of adenocarcinoma, all except one moderately 
differentiated cancer were well differentiated tumor. Therefore, 
38% (95/251) of lesions initially diagnosed as LGD on forceps 
biopsy were upgraded after ER (Table 1).
Examples of histological discrepancies are provided in Figs. 1 
and 2. Fig. 1 shows a lesion that was upgraded to HGD, whereas 
Fig. 2 shows a lesion that was upgraded to an adenocarcinoma.
 
3. Factors related to the histological discrepancy between 
forceps biopsy specimens and ER specimens
A comparison of the lesion and patient characteristics ac-
cording to UH or CDH group is provided in Table 2. In 39 of 95 
cases (41%) with UH, the lesion size was larger than 15 mm. 
Of 156 cases with CDH, only 37 cases (23.7%) were larger than 
15 mm. Fifty-two of 95 cases (54.7%) with UH had a depressed 
portion present in the lesion; however, 52 of 156 cases (33.3%) 
with CDH had a depressed portion in the lesion. Sixty-five of 95 
cases (68.4%) with UH had surface nodularity, while 72 of 156 
cases (46.2%) with CDH had surface nodularity.
On univariate analysis, a large size, presence of a depressed 
portion, and surface nodularity were significantly related to UH 
(Table 2). On multivariate analysis of risk factors of UH, a large 
size and a depressed lesion were significant risk factors for UH 
after ER of lesions diagnosed as LGD by forceps biopsy (odds 
ratios of 2.8 and 2.7, respectively) (Table 3). There were no sig-
nificant associations between UH and age, sex, surface redness, 
number of forceps biopsy specimens, H. pylori infection, or in-
Fig. 1. A lesion with a histologic upgrade from low-grade dysplasia (LGD) to high-grade dysplasia (HGD) following endoscopic resection. (A) En-
doscopic findings of the lesion based on indigo-carmine spray. Endoscopy reveales a 15 mm elevated mucosal lesion with surface nodularity and 
redness on the posterior wall of the angle. (B) Following endoscopic resection, a 2 cm mucosal defect is observed. (C) Microscopic features of the 
forceps biopsy. The biopsy specimen shows mild glandular disarray and increased cellularity with basally located, enlarged hyperchromatic nu-
clei. These findings are consistent with LGD (H&E stain, ×400). (D) Microscopic features of the resected specimen. This portion of the lesion shows 
marked glandular disarray with vesicular, round nuclei and a marked increase in mitosis. These findings are consistent with HGD (H&E stain, 
×400). (E) Map of the resected specimen. The tumor is 15 mm in diameter, and LGD is mixed with HGD.190  Gut and Liver, Vol. 5, No. 2, June 2011
testinal metaplasia (Tables 2 and 3).
4. Factors related to the endoscopic ﬁ  nding between non-
EGC and EGC
A comparison of the lesion according to non-EGC (early 
gastric cancer) or EGC group is provided in Table 4. In 21 of 39 
cases (53.8%) with EGC, the lesion size was larger than 15 mm. 
Of 212 cases with non-EGC, only 55 cases (25.9%) were larger 
than 15 mm. Twenty-eight of 39 cases (71.8%) with EGC had 
a depressed portion present in the lesion; however, 86 of 212 
cases (40.6%) with non-EGC had a depressed portion in the le-
sion. Twenty-seven of 39 cases (71.8%) with EGC had surface 
nodularity, while 111 of 212 cases (52.4%) with non-EGC had 
surface nodularity.
On univariate analysis, a large size, presence of a depressed 
portion, and surface nodularity were significantly related to 
EGC (Table 4).
DISCUSSION
Gastric dysplasia is known to be a precursor lesion of gastric 
carcinoma and is classified as “noninvasive neoplasia” by the 
Padova International Classification system.
2 Gastric dysplasia 
can be categorized as low-grade or high-grade based on the 
severity of histological abnormalities using a two-tier system.
12 
The characteristics of LGD are multiple small, round, glandular 
structures similar to adenomatous polyps in the colon. However, 
it is often difficult to discriminate gastric dysplasia in practice 
for several reasons. The first reason is interobserver variability. 
Fertitta et al.
8 reported that 51% of cases initially diagnosed as 
moderate dysplasia by general pathologists were confirmed as 
hyperplastic or metaplastic lesions. The second reason is speci-
men size. Because the specimens obtained using forceps biopsy 
are tiny and often break into splinters, the whole lesion is not 
represented and the disease severity may be under-diagnosed. 
A third reason is the pathophysiology of gastric carcinogenesis. 
Fig. 2. A lesion with a histologic upgraded from low-grade dysplasia (LGD) to adenocarcinoma following endoscopic resection. (A) Endoscopic 
findings of the lesion based on indigo-carmine spray. Endoscopy reveales a 40 mm flat mucosal lesion with surface nodularity in the lesser cur-
vature side of the angle to the mid body. (B) A large mucosal defect following endoscopic submucosal dissection is noted over the gastric angle. 
(C) Microscopic features of the forceps biopsy specimen. The biopsy specimen shows increased cellularity, and the surface epithelium had a vil-
lous appearance with elongated cigar-shaped nuclei confined to the basal half of the epithelial cells. These findings are consistent with LGD (H&E 
stain, ×200). (D) Microscopic features of the resected specimen. The glandular architecture is severely distorted by marked proliferation of disar-
rayed glands with invasion. This finding is consistent with well differentiated adenocarcinoma confined to the lamina propria (H&E stain, ×400). (E) 
Mapping of the resected specimen. The tumor is 45 mm in size, and focal cancerous lesions mixed with LGD are evident. The lateral and vertical 
margins are free from tumor.Won CS, et al: Endoscopic Features of Upgraded Histology of Gastric Dysplasia  191
A series of changes have been identified as precursors to the 
intestinal type of gastric carcinoma, representing apparently 
sequential steps in the precancerous process, namely superficial 
gastritis, chronic atrophic gastritis, intestinal metaplasia, dys-
plasia, and cancer.
13 Similarly, the genetic evolution of cancer 
involves the accumulation of multiple mutations. In gastric 
cancer, altered loci include p53, APC, K-ras, and there is also 
microsatellite instability in cancers with a replication error (RER) 
or ubiquitous somatic mutation (USM) phenotype.
14 Thus, vari-
ous degrees of dysplasia can coexist in the same lesion, making 
the lesion heterogeneous. Despite these limitations, however, 
endoscopic biopsy results are essential for clinicians to formu-
late their treatment plan. In this study, we investigated which 
endoscopic features were risk factors for upgrading a lesion 
initially diagnosed as LGD based on forceps biopsy. We focused 
on LGD histology for several important reasons. First, LGD has 
a histologically vague position. Until very recently, there was 
a substantial lack of agreement on the issue of dysplasia and 
its grading among pathologists, especially between those from 
Japan and Western countries. As a result of two consensus con-
ferences held in Padova and Vienna, we now have the Padova 
International Classification
2 and the Vienna Classification.
12 
When the pathologists involved in creating the Padova Classi-
fication participated in a test of variability after the conference, 
there was general agreement between them 77.7% to 86.5% of 
the time.
17 The κ coefficients were a little over 0.6, indicating 
moderately good agreement. However, interobserver variability 
in diagnosing dysplasia is inevitable whenever a continuous 
spectrum is subjectively divided. The difficulty in differentiating 
reactive from dysplastic changes may account for reports of the 
reversibility of LGD.
18 For this reason, interobserver variability 
could occur more often in LGD cases. In our study, a single ex-
pert gastrointestinal pathologist reviewed forceps biopsy materi-
als and resected specimens, thereby ensuring no interobserver 
variability.








Age, mean±SD 63.9±9.7 61.8±10.1 NS
Sex
  Male 68 107 NS
  Female 27   39
Size of lesion <0.05
  ≤15 mm 56 119
  >15 mm 39   37
No. of forceps biopsies
  1-2 54   92 NS
  ≥3 41   64
Surface redness NS
  Positive (+) 42   54
  Negative (-) 53 102
Depressed portion <0.05
  Positive (+) 52   52
  Negative (-) 43 104
Surface nodularity
  Positive (+) 65   72 <0.05
  Negative (-) 30   84
Helocobacter pylori infection
  Positive (+) 48   73  NS
  Negative (-) 47   83
Intestinal metaplasia
  Positive (+) 84 129 NS
  Negative (-) 11   27
UH, upgraded histology; CDH, concordant or down-graded histology; 
NS, not significant.
Table 3. Multivariate Analysis of Risk Factors for UH Following En-
doscopic Resection
Factor OR (95% CI) p-value
Large size, >15 mm 2.8 (1.46-5.43) 0.002
Depressed portion (+) 2.7 (1.44-5.03) 0.002
Surface nodularity (+) 1.7 (0.90-3.12) 0.104
Age, >65 yr 1.4 (0.82-2.57) 0.203
No. of forceps biopsies 1.1 (0.84-1.32) 0.675
Surface redness (+) 1.0 (0.55-1.82) 0.999
Intestinal metaplasia (+) 1.6 (0.72-3.75) 0.239
Helicobacter pylori infection (+) 1.5 (0.82-2.57) 0.203
UH, upgraded histology; OR, odds ratio; CI, confidence interval.








  ≤15 mm 157 18 <0.05
  >15 mm   55 21
Surface redness
  Positive (+)   84 13 NS
  Negative (-) 128 26
Depressed portion
  Positive (+)   86 28 <0.05
  Negative (-) 126 11
Surface nodularity
  Positive (+) 111 27 <0.05
  Negative (-) 101 12
EGC, early gastric cancer; NS, not significant.192  Gut and Liver, Vol. 5, No. 2, June 2011
Second, the best treatment option for LGD is unclear. Using 
the two-tier system of classification, low-grade dysplasia was 
shown to regress in between 38% and 49% of cases, to persist 
in 19% to 28%, and to progress to high-grade dysplasia in be-
tween 0% and 15% of cases. High-grade dysplasia regressed in 
about 5% of cases, persisted in 14%, and progressed in 81% to 
85%.
17,19 For these reasons, a lesion diagnosed as high-grade 
dysplasia by endoscopic forceps biopsy material should be 
considered for ER.
6,7 Several long-term follow-up studies have 
demonstrated that LGD lesions do not progress rapidly to HGD 
or carcinoma, thus some authors have advocated a management 
approach of scheduled endoscopic surveillance and re-biopsy.
9,20 
However, other groups have suggested removal of the LGD le-
sions because of the histological discrepancy between forceps 
biopsy specimens and resected specimens.
21-23 In our study, sub-
stantial lesions initially characterized as LGD based on forceps 
biopsy were up-graded after ER (39%), whereas only 2% of le-
sions were down-graded. Furthermore, scarring changes in the 
lesion due to multiple biopsies could interfere with ER. Hull et 
al.
24 reported that EMR is superior to biopsy for the diagnostic 
evaluation of large lesions. Therefore, endoscopic forceps biopsy 
findings as well as endoscopic findings known to be related to 
upgrading of lesions should be considered when planning the 
management of LGD lesions. 
The histological discrepancy between endoscopic biopsy 
specimens and surgical specimens has been reported to range 
from 25% to 40%.
13-16,25-27 In our study, a histological discrepan-
cy between the forceps biopsy specimens and the ER specimens 
was confirmed in 100/251 (39.8%) of total cases. We therefore 
hypothesized that important information could be extracted 
from the endoscopic findings. Recent studies reported that large 
lesions (>15 mm), redness, nodularity of surface lesions, and 
the presence of a depressed portion were markers for malig-
nancy risk.
4,5 Furthermore, adenomatous polyps with a diameter 
greater than 2 cm size have been regarded as having malignant 
potential.
28 In our study, lesions larger than 15 mm, those with 
a depressed portion, and those with surface nodularity were 
more often presented in the UH group than the CDH group. In 
addition, these parameters were more often presented in the 
EGC group than the non-EGC group based on final pathologic 
reports (Table 3). In the multivariate analysis, the risk of UH was 
increased significantly by 2.8-fold in lesions larger than 15 mm 
and 2.7-fold in lesions with a depressed portion. These results 
suggest that the size of lesions and the existence of a depressed 
portion may be risk factors related with UH. In our study 
39/251 (15.5%) cases were diagnosed as EGC after ER. Accord-
ing to several studies in Korea, the proportion of cancer patients 
who were initially diagnosed as LGD but finally diagnosed by 
resection pathology ranged from 7.8% to 34%,
29-33 which was 
consistent with our data. One explanation for high percentage 
of EGCs in almost study was that every study included only 
endoscopically resected cases which were likely to be high risk 
of cancer. Interestingly, 5 cases (2.1%) were reported as gastritis 
after ER. With regard to this point, Kim et al.
34 reported that 3.2% 
was found to be negative after ER and this was similar to our 
result. They suggested several possible reasons for this; small 
tumors removed by the previous forceps biopsy, sampling error 
and a different location. 
However, our study had some limitations. First, there is the 
possibility of selection bias because this study was performed 
retrospectively. Unfortunately, we could not present the exact 
number of LGD patients who might not be treated due to old 
age or comorbidity, or treated in another hospital because we 
searched the cases with key words of LGD and ER in a retro-
spective manner. Also, we had a difficulty to find the number 
of LGD diagnosed in our institution during the study period, 
because our medical records was determined by the final diag-
nosis of ER, the gold standard of this study. Endoscopic ablation 
for LGD was performed in only 2 cases. Because we included 
all cases of endoscopically resection during the study period, 
the number of LGD cases who may not be included in the study 
should be small. Therefore, it’s very unlikely these cases affect 
the results of this study. Second, the concordance rate of endo-
scopic findings between observers was not investigated. Third, 
the number of forceps biopsies performed per patient differed. 
Further prospective studies are required to address these limita-
tions. 
In conclusion, we suggest that additional ER should be prefer-
entially considered for lesions with a depressed portion or those 
larger than 15 mm, even if endoscopic biopsy shows LGD. 
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